News
Moderna stock has faced heavy pressure from negative headlines, regulatory setbacks and political uncertainty. See why I ...
Novartis AG beats Q2 2025 expectations, but patent expiries and policy risks loom. Click for my updated look at NVS earnings ...
Sales growth driven by continued strong performance from Kisqali (+64% cc), Entresto (+22% cc), Kesimpta (+33% cc), Scemblix (+79% cc), Leqvio (+61% cc) and Pluvicto (+30% cc) Core operating income ...
Detailed price information for Mobileye Global Inc Cl A (MBLY-Q) from The Globe and Mail including charting and trades.
Detailed price information for Mobileye Global Inc Cl A (MBLY-Q) from The Globe and Mail including charting and trades.
Zacks Investment Research on MSN18h
Here's Why Moderna (MRNA) Fell More Than Broader MarketModerna (MRNA) ended the recent trading session at $31.25, demonstrating a -2.95% change from the preceding day's closing price. This move lagged the S&P 500's daily loss of 0.01%. Elsewhere, the Dow ...
Zacks Investment Research on MSN1d
Molina to Report Q2 Earnings: Healthy Revenues, Weak Pulse on EarningsHealthcare plan provider, Molina Healthcare, Inc. MOH, is set to report second-quarter 2025 results on July 23, 2025, after ...
International Business Machines said Thursday that it had joined forces with Moderna for a case study that evidenced quantum ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback